• Explore /
  • Poster
  • / Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Abstract Poster

Authors

null

Robert L. Ferris

Hillman Cancer Center, Pittsburgh, PA

Robert L. Ferris , Yael Flamand , Harry Quon , Gregory S. Weinstein , Ranee Mehra , Joaquin J. Garcia , Seungwon Kim , Bert W. O'malley Jr., Enver Ozer , Giovana R. Thomas , Wayne Koch , Michael Elliot Kupferman , Richard Bryan Bell , Mihir Patel , Miriam Lango , Barbara Burtness

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT01898494

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6036)

DOI

10.1200/JCO.2023.41.16_suppl.6036

Abstract #

6036

Poster Bd #

28

Abstract Disclosures

Similar Posters

First Author: Ranee Mehra

First Author: Hongyu Pan

First Author: Daniel McGrail

First Author: Jesse Meir Zaretsky